The company conducts research and development, manufacturing, and sales of a wide range of pharmaceutical and healthcare products. It offers distribution, warehousing, logistics, and other value-added supply chain solutions to pharmaceutical manufacturers and dispensers. With dual listings on the stock exchanges in Shanghai and Hong Kong, Shanghai Pharmaceutical is a major player in the industry, generating revenues of US$26.5bn in 2019. It holds a leading position in both manufacturing and distribution in China and is included in prominent stock indices such as SSE 180, CSI 300, and MSCI.